Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams.

ABSTRACT:

Unlabelled

Most β-lactam antibiotics are ineffective against Mycobacterium tuberculosis due to the microbe's innate resistance. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains has prompted interest to repurpose this class of drugs. To identify the genetic determinants of innate β-lactam resistance, we carried out a synthetic lethality screen on a transposon mutant library for susceptibility to imipenem, a carbapenem β-lactam antibiotic. Mutations in 74 unique genes demonstrated synthetic lethality. The majority of mutations were in genes associated with cell wall biosynthesis. A second quantitative real-time PCR (qPCR)-based synthetic lethality screen of randomly selected mutants confirmed the role of cell wall biosynthesis in β-lactam resist

SUBMITTER: Lun S 

PROVIDER: S-EPMC4172077 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature